The Hong Kong Economic and Trade Office, New York (HKETONY) organized a roundtable luncheon at the BIO International Convention in Philadelphia (Jun 4) to promote opportunities and strengths in Hong Kong’s biotechnology development, and to encourage US biotechnology businesses to leverage the city’s advantages to grow. Speakers included the Senior Vice President of the Markets Division at the Hong Kong Exchanges and Clearing Limited Michael Chan; Director of the BioMedical Technology Cluster of Hong Kong Science and Technology Parks Corporation Prof. Cesar Wong; the Chairman of the Hong Kong Biotechnology Organization, Prof. Albert Yu; Director of the Hong Kong Trade Development Council in New York Anna Fan; and Associate Director-General of Invest Hong Kong Charles Ng. They highlighted Hong Kong’s booming biotechnology ecosystem including listing and fund-raising opportunities, and the latest developments in the biotechnology and biomedical landscape in the city.
Director of the HKETONY Joanne Chu said Hong Kong’s appeal as a biotechnology hub continues to gain traction, with the introduction of new measures and investment by the Government. In addition, the Guangdong-Hong Kong-Macao Greater Bay Area development will bring further opportunities for the biotechnology industry in the region. At the convention, Ms Chu met New Jersey Governor Phil Murphy and updated him on the latest biotech developments in the city.